© ZIMBABWE has started using a generic version of the latest HIV/Aids drug that can improve and prolong the lives of people who suffer severe side effects and resistance to other treatments. [GoogleAd] A generic of Dolutegravir (DTG), first approved in the United States in 2013, is to start being given to people living with…
To access this content, please purchase a subscription by clicking the button below and select a package of your choice!
Subscriptions